Cancer Drug Shortages: Why the ASCO and FDA Resource Pages Matter

In brief

Cancer drug shortages remain an important access issue. ASCO keeps a drug-shortage resource page for oncology professionals, and the FDA maintains a drug-shortage database and reporting process.

For patients and caregivers, the most important message is practical: do not assume a headline means your treatment is unavailable, and do not change treatment on your own. Ask your oncology team whether a shortage affects your exact medication, dose, schedule, or treatment center.

What happened

ASCO's drug-shortage pages continue to collect clinical guidance, policy updates, and disease-specific resources. FDA's drug-shortage page explains how shortage information is gathered, how the public can report local shortages, and how the agency defines current and resolved shortages.

This matters because some cancer treatments rely on older generic medicines. These drugs may be inexpensive compared with newer medicines, but they can be hard to replace when supply is limited.

Why shortages are different from other cancer news

A drug shortage is not a new discovery. It is a failure of access, manufacturing capacity, supply-chain resilience, or market incentives.

The result can be stressful for patients and clinicians. A care team may need to check local supply, substitute a medicine, adjust timing, prioritize limited supply according to clinical need, or refer a patient to another site. ASCO's guidance emphasizes evidence-based alternatives and multidisciplinary decision-making when shortages affect care.

What this does not mean

• It does not mean every cancer drug is in shortage.
• It does not mean your treatment plan has changed unless your care team tells you it has.
• It does not mean patients should skip doses, stretch medicines, or delay treatment without medical guidance.
• It does not mean every alternative regimen is equal for every patient.
• It does not mean the problem is only local; some shortages are national, while others are temporary or regional.

What patients can do

If you hear about a shortage, ask specific questions rather than trying to interpret national lists by yourself.

Useful questions include:

• Is any medicine in my current plan affected by a shortage?
• If yes, is the shortage at this treatment center, in this region, or national?
• Is there an equivalent or evidence-supported alternative?
• Would changing timing, dose, or sequence affect my treatment goal?
• Who will call me if my appointment or infusion plan changes?
• Is there a social worker, navigator, or financial counselor who can help with access problems?

How to read shortage pages

The FDA database is important, but it is not a personal treatment plan. A drug can be listed as available, in shortage, resolved, or discontinued, and manufacturer information can change.

ASCO guidance is written mainly for oncology teams. It can help patients understand the ethical and clinical principles behind decisions, but individual decisions still depend on cancer type, stage, treatment intent, alternatives, and local supply.

Sources

This article was written from the sources below, which were checked on July 18, 2026.

• American Society of Clinical Oncology. Drug Shortages resource page.
• American Society of Clinical Oncology. Clinical Guidance for oncology drug shortages.
• U.S. Food and Drug Administration. Drug Shortages page and Drug Shortage FAQs.
• National Cancer Institute background pages on cancer treatment and questions to ask about treatment.

How this article was prepared

Prepared by Cancer Explained's AI-assisted editorial system and checked against the sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.

Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.

Found an error, a broken source link, outdated information, or wording that feels unsafe or unclear? Report it here - we log and act on material corrections.